Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, indicating a small update to the page version. No study data or displayed details were changed.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer revision label changed from v3.6.2 to v3.6.3, indicating a version update to the ClinicalTrials.gov study details page. This update does not alter the study data or how a user interacts with the page.
    Difference
    0.0%
    Check dated 2026-07-05T12:27:12.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a new release of the page. This appears to be a technical revision rather than a change to the study details or content visible to users.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:09.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading; it also updates the revision label to v3.6.0 and notes that recruitment is closed with a 'No longer looking for participants' statement.
    Difference
    0.4%
    Check dated 2026-06-14T05:08:04.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a minor administrative update. No study content or data were changed.
    Difference
    0.1%
    Check dated 2026-06-06T23:28:43.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The page update introduces revision v3.5.4, replacing the previous v3.5.3. This appears to be a metadata/versioning change without visible user-facing content alterations.
    Difference
    0.1%
    Check dated 2026-05-16T10:05:41.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.